UK markets closed

Forte Biosciences, Inc. (FBRX)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.7141+0.0141 (+2.01%)
At close: 04:00PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
4,458
21,862
5,594
13,853
10,004
Selling general and administrative
7,798
10,624
8,302
7,633
4,221
Total operating expenses
12,256
32,486
13,896
21,486
14,225
Operating income or loss
-12,256
-32,486
-13,896
-21,486
-14,225
Total other income/expenses net
-87
-114
-145
-222
-32,262
Income before tax
-12,343
-31,476
-13,879
-21,708
-46,487
Income from continuing operations
-12,343
-31,476
-13,879
-21,708
-46,487
Net income
-12,343
-31,476
-13,879
-21,708
-46,487
Net income available to common shareholders
-12,343
-31,476
-13,879
-21,708
-46,487
Basic EPS
-0.38
-1.00
-0.80
-1.55
-6.32
Diluted EPS
-0.38
-1.00
-0.80
-1.55
-6.32
Basic average shares
10,800
31,571
17,384
13,968
7,359
Diluted average shares
10,800
31,571
17,384
13,968
7,359